Intravitreal injection of bevacizumab to treat neovascular glaucoma

Jpn J Ophthalmol. 2008 Sep-Oct;52(5):410-412. doi: 10.1007/s10384-008-0573-3. Epub 2008 Nov 11.

Authors

Toshiaki Kubota¹, Rumi Aoki², Yukinori Harada², Norihiko Tou², Akihiko Tawara²

Affiliations

¹ Department of Ophthalmology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan. tkubota@med.uoeh-u.ac.jp.
² Department of Ophthalmology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan.

PMID: 18991046
DOI: 10.1007/s10384-008-0573-3

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Angiogenesis Inhibitors / therapeutic use*
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Humanized
Bevacizumab
Female
Glaucoma, Neovascular / drug therapy*
Humans
Injections
Intraocular Pressure / drug effects
Male
Middle Aged
Vascular Endothelial Growth Factor A / antagonists & inhibitors
Vitreous Body

Substances

Angiogenesis Inhibitors
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Vascular Endothelial Growth Factor A
Bevacizumab